George Farmer
Stock Analyst at Scotiabank
(2.72)
# 2,033
Out of 4,761 analysts
65
Total ratings
38.89%
Success rate
0.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $68.25 | +17.22% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $140.64 | +59.27% | 3 | Feb 13, 2025 | |
| VKTX Viking Therapeutics | Initiates: Sector Outperform | $102 | $34.07 | +199.38% | 1 | Feb 13, 2025 | |
| INMB INmune Bio | Maintains: Sector Outperform | $22 → $23 | $8.59 | +167.75% | 2 | Feb 11, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $18 → $16 | $16.38 | -2.32% | 3 | Jan 8, 2025 | |
| KURA Kura Oncology | Maintains: Sector Perform | $18 → $10 | $8.25 | +21.21% | 2 | Jan 8, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $35 → $47 | $18.57 | +153.10% | 3 | Dec 11, 2024 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $42 → $62 | $36.01 | +72.17% | 3 | Dec 4, 2024 | |
| ARGX argenx SE | Upgrades: Sector Outperform | $439 → $715 | $644.48 | +10.94% | 5 | Nov 5, 2024 | |
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $17 → $14 | $7.31 | +91.52% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $7.51 | +206.26% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $2.98 | +571.14% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $3.46 | +1,084.97% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $39.70 | +91.44% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $3.15 | $0.56 | +463.00% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $4.96 | +162.10% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $0.86 | +1,410.93% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $63.75 | +3.53% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $35.53 | +206.78% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $72.11 | +20.65% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $3.01 | +996.35% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $1.27 | +3,049.61% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $36.85 | -26.73% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $92.25 | -18.70% | 3 | Apr 29, 2020 |
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $68.25
Upside: +17.22%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $140.64
Upside: +59.27%
Viking Therapeutics
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $34.07
Upside: +199.38%
INmune Bio
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $8.59
Upside: +167.75%
Syndax Pharmaceuticals
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $16
Current: $16.38
Upside: -2.32%
Kura Oncology
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $8.25
Upside: +21.21%
NewAmsterdam Pharma Company
Dec 11, 2024
Maintains: Sector Outperform
Price Target: $35 → $47
Current: $18.57
Upside: +153.10%
Janux Therapeutics
Dec 4, 2024
Maintains: Sector Perform
Price Target: $42 → $62
Current: $36.01
Upside: +72.17%
argenx SE
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $644.48
Upside: +10.94%
Sage Therapeutics
Oct 30, 2024
Maintains: Sector Outperform
Price Target: $17 → $14
Current: $7.31
Upside: +91.52%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $7.51
Upside: +206.26%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $2.98
Upside: +571.14%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $3.46
Upside: +1,084.97%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $39.70
Upside: +91.44%
May 30, 2024
Initiates: Sector Outperform
Price Target: $3.15
Current: $0.56
Upside: +463.00%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $4.96
Upside: +162.10%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $0.86
Upside: +1,410.93%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $63.75
Upside: +3.53%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $35.53
Upside: +206.78%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $72.11
Upside: +20.65%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $3.01
Upside: +996.35%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $1.27
Upside: +3,049.61%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $36.85
Upside: -26.73%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $92.25
Upside: -18.70%